Crossmark

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells

Crossref DOI link: https://doi.org/10.1186/s12885-018-4086-2

Published Online: 2018-02-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Galmarini, Carlos M. http://orcid.org/0000-0003-3361-217X
Martin, Maud

Bouchet, Benjamin Pierre

Guillen-Navarro, María José

Martínez-Diez, Marta

Martinez-Leal, Juan Fernando

Akhmanova, Anna

Aviles, Pablo
Funding

Funding for this research was provided by:

PharmaMar SA
More Information

Article History

Received: 7 September 2016

Accepted: 31 January 2018

First Online: 7 February 2018

Ethics approval and consent to participate

: All animal protocols were reviewed and approved by the OEP (Vicerrectorado de Investigación e Innovación) from Universidad Miguel Hernández (Elche, Spain) and were performed in agreement with the directive 2010/63/EU.

: Not applicable.

: Carlos M. Galmarini, María José Guillen-Navarro, Marta Martínez-Diez, Juan Fernando Martinez-Leal, Pablo Aviles are employees and share-holders of Pharma Mar S.A.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.